Autocrine TGF-beta-regulated expression of adhesion receptors and integrin-linked kinase in HT-144 melanoma cells correlates with their metastatic phenotype

Int J Cancer. 1999 Oct 8;83(2):255-62. doi: 10.1002/(sici)1097-0215(19991008)83:2<255::aid-ijc18>3.0.co;2-x.

Abstract

We have previously shown that 2 human melanoma cell lines, the metastatic HT-144 and the non-metastatic SK-Mel-2 cells, exhibit marked in vitro heterogeneity with respect to integrin expression, migration and invasion potential. Here, we provide evidence that HT-144 melanoma cells, but not SK-Mel-2 cells, undergo a reversible transition to a fibroblastoid morphology following treatment with either their own serum-free acidified conditioned medium or biologically active exogenous TGF-beta1, thus identifying TGF-beta as an autocrine regulator of the spindle shape morphology of HT-144 melanoma cells. The fibroblastoid phenotype correlated with up-regulated beta1 and beta3 integrin and down-regulated E-cadherin expression, as shown by flow cytometry, Western blot and RT-PCR, as well as up-regulated expression of the matrix metalloproteinase MMP-9, as demonstrated by zymography. Our data further illustrate the TGF-beta1-dependent up-regulation of integrin-linked kinase and the nuclear translocation of beta-catenin, 2 intracellular proteins involved in integrin and cadherin signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD / biosynthesis*
  • Blotting, Western
  • Cadherins / biosynthesis*
  • Cell Movement
  • Cell Size / drug effects
  • Collagenases / biosynthesis
  • Collagenases / metabolism
  • Down-Regulation
  • Flow Cytometry
  • Humans
  • Integrin beta1 / biosynthesis*
  • Integrin beta3
  • Matrix Metalloproteinase 9
  • Melanoma / enzymology
  • Melanoma / metabolism*
  • Melanoma / pathology
  • Melanoma / secondary*
  • Phenotype
  • Platelet Membrane Glycoproteins / biosynthesis*
  • Protein Serine-Threonine Kinases / biosynthesis*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Scaffold Protein ILK
  • Transforming Growth Factor beta / pharmacology*
  • Tumor Cells, Cultured
  • Up-Regulation

Substances

  • Antigens, CD
  • Cadherins
  • Collagenases
  • Integrin beta1
  • Integrin beta3
  • Matrix Metalloproteinase 9
  • Platelet Membrane Glycoproteins
  • Protein Serine-Threonine Kinases
  • Transforming Growth Factor beta
  • Scaffold Protein ILK